Consistent with this fact, it is shown that combinational treatment with anti-MAdCAM-1, VCAM-1 and ICAM-1 monoclonal antibodies led to more rapid remission in the experimental autoimmune encephalitis (EAE) model of MS than that obtained with individual antibodies alone [39]. This evidence concerns the gene MADCAM1 and myeloid sarcoma.